J, d. L., RJ, B., R, B., J, B., SN, C., L, C., . . . C, D. L. C. (2025). Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes. Journal of clinical psychopharmacology, 45(3), 179. https://doi.org/10.1097/JCP.0000000000001987
Chicago Style (17th ed.) CitationJ, de Leon, et al. "Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes." Journal of Clinical Psychopharmacology 45, no. 3 (2025): 179. https://doi.org/10.1097/JCP.0000000000001987.
MLA (9th ed.) CitationJ, de Leon, et al. "Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes." Journal of Clinical Psychopharmacology, vol. 45, no. 3, 2025, p. 179, https://doi.org/10.1097/JCP.0000000000001987.